WallStreetZenWallStreetZen

NASDAQ: CRBU
Caribou Biosciences Inc Stock Ownership - Who owns Caribou Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Caribou Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rachel E. HaurwitzPresident and CEO2025-03-1420,000$1.02
$20.40kBuy
Steven KannerChief Scientific Officer2025-02-213,564$1.35
$4.81kSell
Ruhi Ahmad KhanChief Business Officer2025-02-213,564$1.35
$4.81kSell
Barbara G. McClungChief Legal Officer2025-02-213,564$1.35
$4.81kSell
Sriram RyaliChief Financial Officer2025-01-2917,360$1.42
$24.65kBuy

1 of 1

CRBU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBU insiders and whales buy or sell their stock.

CRBU Shareholders

What type of owners hold Caribou Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pfizer Inc5.02%4,690,431$9.10MInstitution
Vanguard Group Inc4.52%4,226,926$8.20MInstitution
Rachel E. Haurwitz3.92%3,664,845$7.11MInsider
Fmr LLC3.56%3,323,284$6.45MInsider
Millennium Management LLC3.44%3,216,535$6.24MInstitution
Kynam Capital Management LP3.28%3,067,774$5.95MInstitution
Blackrock Inc1.56%1,459,320$2.83MInstitution
Aberdeen Group PLC1.49%1,388,905$2.69MInstitution
Pfm Health Sciences LP1.45%1,358,831$2.64MInstitution
Two Sigma Advisers LP1.31%1,227,400$2.38MInstitution

1 of 3

CRBU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBU39.75%8.81%Net Buying
NTHI8.71%91.29%Net BuyingNet Buying
GNLX19.57%7.51%Net SellingNet Selling
RNAC12.84%87.16%Net BuyingNet Buying
CRBP40.84%59.16%Net SellingNet Buying
View Top Biotech Stocks

Caribou Biosciences Stock Ownership FAQ

Who owns Caribou Biosciences?

Caribou Biosciences (NASDAQ: CRBU) is owned by 39.75% institutional shareholders, 8.81% Caribou Biosciences insiders, and 51.44% retail investors. Rachel E. Haurwitz is the largest individual Caribou Biosciences shareholder, owning 3.66M shares representing 3.92% of the company. Rachel E. Haurwitz's Caribou Biosciences shares are currently valued at $6.96M.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.